Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Sio Gene Therapies Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SIOX is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 37
- 0 vs. Q3 2022
- Shares held
- 18.6M
- −2.37M (−11.3%) vs. Q3 2022
- Total value
- $8.09M
- +$2.22M (+37.8%) vs. Q3 2022
- New holders
- 6
- 6 more added
- Sold out
- 6
- 13 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $26.0K |
| Q1 2023 | 4 | $1.13M |
| Q4 2022 | 37 | $8.09M |
| Q3 2022 | 38 | $5.91M |
| Q2 2022 | 41 | $7.44M |
| Q1 2022 | 40 | $12.1M |
| Q4 2021 | 48 | $27.6M |
| Q3 2021 | 55 | $39.9M |
| Q2 2021 | 53 | $56.1M |
| Q1 2021 | 55 | $53.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 7,000,000 | $3.04M | 0.13% | 00.0% | Unchanged |
| Newtyn Management, LLC | 3,000,000 | $1.30M | 0.27% | +1,500,000+100.0% | Added |
| Tang Capital Management LLC | 2,000,000 | $870.0K | 0.13% | +2,000,000 | New |
| Vanguard Group Inc | 1,739,923 | $756.9K | 0.00% | −100,784−5.5% | Reduced |
| Morgan Stanley | 1,512,380 | $657.9K | 0.00% | +1,500,000+12,116.3% | Added |
| Geode Capital Management, LLC | 432,270 | $188.0K | 0.00% | −1,116−0.3% | Reduced |
| JBF Capital, Inc. | 429,600 | $186.9K | 0.05% | +429,600 | New |
| Renaissance Technologies LLC | 409,284 | $178.0K | 0.00% | +47,284+13.1% | Added |
| BlackRock Inc. | 390,386 | $169.8K | 0.00% | −70.0% | Reduced |
| Western Standard LLC | 294,397 | $128.1K | 0.11% | +294,397 | New |
| Clearline Capital LP | 250,024 | $108.8K | 0.02% | −142,667−36.3% | Reduced |
| Hudson Bay Capital Management LP | 235,000 | $102.2K | 0.00% | −1,445,536−86.0% | Reduced |
| State Street Corp | 173,621 | $75.5K | 0.00% | 00.0% | Unchanged |
| Cladis Investment Advisory, LLC | 150,000 | $65.3K | 0.06% | −402,000−72.8% | Reduced |
| Susquehanna International Group, LLP | 95,387 | $41.5K | 0.00% | +95,387 | New |
| Northern Trust Corp | 87,153 | $37.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 80,100 | $35.2K | 0.00% | +75,573+1,669.4% | Added |
| Two Sigma Investments, LP | 70,925 | $30.9K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 64,170 | $28.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 55,570 | $24.2K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 30,000 | $13.1K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,453 | $7.00K | 0.00% | −22,853−59.7% | Reduced |
| Merit Financial Group, LLC | 15,750 | $6.85K | 0.00% | −2,000−11.3% | Reduced |
| Bridgeway Capital Management, LLC | 15,600 | $6.79K | 0.00% | −89,800−85.2% | Reduced |
| Citadel Advisors LLC | 15,202 | $6.61K | 0.00% | +15,202 | New |
| StoneX Group Inc. | 13,913 | $6.05K | 0.00% | +13,913 | New |
| Primecap Management Co | 12,000 | $5.22K | 0.00% | −3,600−23.1% | Reduced |
| Wolff Wiese Magana LLC | 2,400 | $1.04K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,373 | $1.03K | 0.00% | +2,011+555.5% | Added |
| Capital Advisors, Ltd. LLC | 1,305 | $1.00K | 0.00% | −687−34.5% | Reduced |
| Group One Trading, L.P. | 902 | $392 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 244 | $106 | 0.00% | +130+114.0% | Added |
| Fifth Third Bancorp | 125 | $54 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 125 | $54 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 132 | $0 | 0.00% | −184−58.2% | Reduced |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | 00.0% | Unchanged |
| Tower View Investment Management & Research LLC | 5,239 | – | – | −6,406−55.0% | Reduced |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −5,914,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −99,324−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −94,150−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Hudock, Inc. | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |